Results 331 to 340 of about 324,464 (367)

Challenges and Opportunities of Direct Oral Anticoagulant (DOAC) Therapy in Complex Clinical Scenarios: A Comprehensive Review and Practical Guide. [PDF]

J Clin Med
Miceli G, Ciaccio AM, Tuttolomondo A.
europepmc   +1 more source

Prevention and Management of Thromboembolism in Patients with Paroxysmal Nocturnal Hemoglobinuria in Asia: A Narrative Review. [PDF]

Int J Mol Sci
Ueda Y, Chou WC, Goh YT, Rojnuckarin P, Kim JS, Wong RSM, Lee Wong LL, Jang JH, Chiou TJ, Kanakura Y, Lee JW.   +10 more
europepmc   +1 more source

Effect of antiplatelet and anticoagulant medications on implant survival: a long-term retrospective cohort study. [PDF]

Oral Maxillofac Surg
Chatzopoulos GS, Wolff LF.
europepmc   +1 more source

Atrial fibrillation is associated with lower likelihood of first-pass effect in thrombectomy for medium vessel occlusion acute ischemic strokes.

Interv Neuroradiol
Elgendy O, Dubinski MJ, Yi Z, Vij S, Thomas T, Charcos I, Badger C, Patel K, Penckofer M, Santucci J, Ballout A, Khalife J, Thon JM, Schumacher HC, Hanafy KA, Patel PD, Tonetti DA, Shaikh HA, Jovin TG, Koneru M.   +19 more
europepmc   +1 more source

Genetic cardiomyopathy mimicking isolated cardiac sarcoidosis: Diagnostic challenges with positron emission tomography

ESC Heart Failure, Volume 12, Issue 3, Page 2347-2352, June 2025.
Daigo Nishijo, Shunsuke Inoue, Zhehao Dai, Seitaro Nomura, Ryo Abe, Takashi Hiruma, Chie Bujo, Tsukasa Oshima, Manami Katoh, Yu Shimizu, Masamichi Ito, Kenichiro Yamagata, Junichi Ishida, Eisuke Amiya, Norifumi Takeda, Katsuhito Fujiu, Masaru Hatano, Hiroyuki Morita, Norihiko Takeda, Issei Komuro   +19 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

New anticoagulants

Current Opinion in Hematology, 2006
Abstract Traditional anticoagulant drugs, including unfractionated heparin and warfarin, have several limitations. New anticoagulants have been developed that target a single coagulation factor and have predictable dose-response relationships. These include direct thrombin inhibitors and factor Xa inhibitors.
AGNELLI, Giancarlo, BECATTINI, Cecilia
openaire   +6 more sources

Anticoagulation

Clinical Obstetrics and Gynecology, 1998
Outpatient management of women requiring treatment and prophylaxis against thromboembolic conditions during pregnancy and the postpartum period requires a coordinated effort between the patient, her obstetrician and, in certain cases, a hematologic consultant.
H L, Brown, R A, Bobrowski
openaire   +2 more sources

Pharmacology of Anticoagulants

Disease-a-Month, 2012
Antithrombotic drugs are used for the prevention and treatment of thrombosis. Targeting the various components of thrombosis, these agents include (1) antiplatelet agents; (2) anticoagulants; and (3) fibrinolytic agents. This review focuses on anticoagulants.
Loke, Chandravathi, MD, Ali, Syed, MD, Johari, Vandita, MD   +2 more
openaire   +3 more sources

Novel anticoagulants and the future of anticoagulation

Thrombosis Research, 2009
Since its discovery during the first half of the 20th century by biochemists at the University of Wisconsin, warfarin (along with other vitamin K antagonists) has remained the only oral anticoagulant available to patients at risk for thromboembolism. After nearly 6 decades in clinical practice, we have learned much about warfarin. Although it is highly
openaire   +3 more sources

Anticoagulation clinics and the monitoring of anticoagulant therapy

International Journal of Cardiology, 1988
Patients attending an anticoagulation clinic were studied to delineate predisposing risk factors for bleeding and thromboembolic episodes. Seventy-three patients were observed for a total of 921.8 patient-treatment months. The mean duration of treatment was 12.6 months (range 3-36 months).
Richard Charney, David N. Rose, Valentin Fuster, Elaine Leddomado   +3 more
openaire   +3 more sources